Skip to Content

Netspot FDA Approval History

FDA Approved: Yes (First approved June 1, 2016)
Brand name: Netspot
Generic name: gallium Ga 68 dotatate
Dosage form: Injection
Company: Advanced Accelerator Applications USA, Inc.
Treatment for: Diagnosis and Investigation

Netspot (gallium Ga 68 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors

Development Timeline for Netspot

Jun  1, 2016Approval FDA Approves Netspot (gallium Ga 68 dotatate) Imaging Agent to Detect Rare Neuroendocrine Tumors

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.